Table 2 Clinical and imaging data for different phases of the study. P values are provided for each component
Pre-intervention | Interim-intervention | Post-intervention | P | |
|---|---|---|---|---|
Number | 14 | 39 | 45 | |
Age, mean ± SD | 61.57 | 66.87 | 65.29 | 0.434 |
Male, n, % | 11 (78.6%) | 30 (76.9%) | 31 (68.9%) | 0.643 |
Hypertension, n, % | 6 (42.9%) | 24 (61.5%) | 30 (66.7%) | 0.679 |
AF, n, % | 6 (42.9%) | 13 (33.3%) | 17 (37.8%) | 0.802 |
DM, n, % | 1 (7.1%) | 6 (15.4%) | 11 (24.4%) | 0.284 |
CAD, n, % | 4 (28.6%) | 9 (23.1%) | 9 (20.0%) | 0.792 |
Previous Stroke, n, % | 1 (7.1%) | 10 (25.6%) | 9 (20.0%) | 0.336 |
Dyslipidemia, n, %, | 1 (7.1%) | 5 (12.8%) | 9 (20.0%) | 0.434 |
CKD, n, % | 0 (0.0%) | 3 (7.7%) | 7 (15.6%) | 0.193 |
Smoker, n, % | 7 (50.0%) | 12 (30.8%) | 9 (20.0%) | 0.088 |
mRS pre-treatment (IQR) | 0.0 (0.0,0.0) | 0.0 (0.0,0.0) | 0.0 (0.0,0.0) | 0.597 |
pre-treatment ASPECTS (IQR) | 9.0 (8.0,9.0) | 8.0 (8.0,9.0) | 8.0 (7.5,9.0) | 0.184 |
Admission NIHSS (IQR) | 19.0 (11.0,21.0) | 14.0 (11.0,18.0) | 17.0 (14.0,21.0) | 0.026 |
Vessels occlusion | ||||
ICA, n, % | 2 (14.3%) | 8 (20.5%) | 6 (13.3%) | 0.697 |
M1, n, % | 5 (35.7%) | 16 (41.0%) | 22 (48.9%) | |
M2, n, % | 0 (0.0%) | 1 (2.6%) | 0 (0.0%) | |
Basilar artery, n, % | 5 (35.7%) | 8 (20.5%) | 14 (31.1%) | |
Tandem, n, % | 2 (14.3%) | 6 (15.4%) | 3 (6.67%) | |
TOAST type | ||||
LAA, n, % | 3 (21.4%) | 22 (56.4%) | 19 (42.2%) | 0.028 |
CE, n, % | 6 (42.9%) | 15 (38.5%) | 22 (51.2%) | |
SVO, n, % | 0 (0.0%) | 1 (2.6%) | 0 (0.0%) | |
SOE, n, % | 3 (21.4%) | 0 (0.0%) | 2 (4.4%) | |
SUE, n, % | 2 (14.3%) | 1 (2.6%) | 2 (4.4%) | |
IV Thrombolysis, n, % | 7 (50.0%) | 18 (46.2%) | 23 (51.1%) | 0.942 |